VIDEO - UC Davis to Test Experimental Drug for Laminitis in Horses

VIDEO – UC Davis to Test Experimental Drug for Laminitis in Horses

A UC Davis entomologist and veterinarians believe they may have a successful treatment for laminitis. The equine hoof ailment is one of the oldest recognized horse diseases that often leads to euthanasia.

Home » VIDEO – UC Davis to Test Experimental Drug for Laminitis in Horses

ABOUT THE AUTHOR

Stable Management

SHARE THIS STORY

Join us for the Ultimate Equine Celebration: Horse Week, Presented by Boehringer Ingelheim

Equine Network Partners with Absorbine® and Sentinel® to Launch My New Horse

AHC Seeks Participants for the 2023 Equine Economic Impact Survey

English Riding Supply Recalls Ovation Protégé Equestrian Helmets Due to Impact Injury Hazard

Equine Industry and Animal Welfare Organizations Announce Collaborative Effort to Ban Horse Slaughter

GET NEWS & UPDATES

"*" indicates required fields

The latest from Stable Management, the #1 resource for horse farm and stable owners, managers and riding instructors, delivered straight to your inbox.

Name*

Email*

Phone

Country*

Additional Offers

Stable Management Partner Offers - Busy? Stay in the know with Stable Management! Receive news and promotions from Stable Management’s and the Equine Network’s carefully selected partners.

Stable Management Special Offers - Receive news and promotions for Stable Management and other Equine Network offers.

Stable Management Extra - Stable Management Extra provides private and commercial horse farm and stable owners/managers and riding instructors the latest innovations in horse care and facility management right to your inbox.

SMS Notifications - I would like to receive text messages with special offers and more from Equine Network and its affiliates. Data rates may apply.

By clicking "subscribe", I consent to Equine Network’s Privacy Policy and Terms of Service and I represent that I am over 16 years old.

CAPTCHA

This field is for validation purposes and should be left unchanged.

FOLLOW US

FOLLOW US

FOLLOW US

FOLLOW US